Form D · Biotechnology
DoubleRainbow Biosciences Inc.
Cambridge, MA · CIK 0001749735
Offering snapshot reported Nov 4, 2020 · SEC filing
- Reported sold
- $10M Offering amount: $20M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 26, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 4, 2020 | Initial | $10,000,000 | No comparison | 1 | SEC filing |
| Apr 22, 2019 | Initial | $3,000,000 | No comparison | 2 | SEC filing |
| Aug 13, 2018 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-379715
Source: Form D, filed Nov 4, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Wei Gong | Executive |
| Jing Ke Weng | Director, Executive |
| Tian Xu | Director, Executive |
| Wan Yu | Executive |
| John Yu | Director |
| Jiangtao Yu | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
840 Memorial Drive, 1 St Floor
Cambridge, MA, 02139
Cambridge, MA, 02139